Alito Angelo, Basile Giorgio Carmelo, Bruschetta Daniele, Berescu Gina Lacramioara, Cavallaro Filippo, Postorino Aurelio Daniele, Scarcella Eliseo, Ragonese Marta, Cannavò Salvatore, Tisano Adriana
Policlinico Universitario G. Martino, Messina, Italy.
University of Messina, Messina, Italy.
Folia Med (Plovdiv). 2023 Feb 28;65(1):37-45. doi: 10.3897/folmed.65.e68278.
Despite successful therapy, acromegalic patients have reduced health-related quality of life (HRQoL) compared to healthy controls. Finding predictors of poor HRQoL can be crucial to improving these patients' global health state. Aim: The primary objective of the study was to find out predictors of HRQoL. Secondary objectives were: (I) to determine correlations with AcroQoL subscales, and (II) to identify predictors for subscales.
In this cross-sectional study conducted in 2019 at the Messina Policlinic Hospital, 45 acromegalic patients were assessed at the Physical and Rehabilitative Medicine Ambulatory. During routine outpatient clinic attendances, the following questionnaires were administered: Acromegaly Quality of Life Questionnaire (AcroQoL), Patient-Assessed Acromegaly Symptom Questionnaire (PASQ), and Western Ontario and McMaster Universities Arthritis Index (WOMAC). We furthermore included the following variables obtained by medical record review: age, BMI, disease duration, previous surgery (Yes/No), previous radiotherapy (Yes/No), use of GH lowering medications (Yes/No), hypertension (Yes/No), diabetes mellitus (Yes/No), and biochemical control of the disease (Yes/No): immunoradiometric assays were employed to serum GH and IGF-1 measurements to identify biochemical control of the disease. Correlation between outcome measures and AcroQoL has been performed. Pearson's r was calculated for continuous data following normal distribution (AcroQoL, PASQ, AcroQoL-B, AcroQoL-R, WOMAC-P), while Spearman's rank order correlation was calculated for non-normally distributed data (WOMAC, WOMAC-F, WOMAC-S, AcroQoL-P) and point-biserial correlation for binary variables (biochemically controlled disease, use of GH lowering medications, radiotherapy, surgery). The same correlation analysis was performed for the AcroQoL subscales. Multiple linear regression with backwards, stepwise analysis was used to assess the influence on AcroQoL of correlated variables.
AcroQoL was strongly negatively correlated with PASQ (r=-0.700, p<0.001) and negatively correlated with WOMAC [rs (43)=-0.530, p<0.001] and among WOMAC subscales with WOMAC-Physical fitness [rs (43)=-0.518, p<0.001] WOMAC-Pain [r (43)=-0.428, p=0.003], WOMAC-Stiffness [rs (43)=-0.393, p=0.007], and radiotherapy [r (43) =-0.314, p=0.035]. After univariate stepwise regression, PASQ was the strongest independent predictor of AcroQoL, with R2 of 0.392 [F (1,43)=27.695, p<0.001].
This study shows that the severity of painful symptoms is the most important predictor of HRQoL in patients with acromegaly; at the same time, acromegalic arthropathy leads to pain and to a variable amount of functional impairment, exerting great impact on the patient's perception of his health status. Measure of the progression of arthropathy and symptomatic management could lead to a great HRQoL benefit.
尽管治疗取得成功,但与健康对照者相比,肢端肥大症患者的健康相关生活质量(HRQoL)仍有所下降。找出HRQoL较差的预测因素对于改善这些患者的整体健康状况至关重要。目的:本研究的主要目标是找出HRQoL的预测因素。次要目标为:(I)确定与肢端肥大症生活质量量表(AcroQoL)各子量表的相关性,以及(II)确定各子量表的预测因素。
在2019年于墨西拿综合医院进行的这项横断面研究中,45例肢端肥大症患者在物理与康复医学门诊接受了评估。在常规门诊就诊期间,发放了以下问卷:肢端肥大症生活质量问卷(AcroQoL)、患者自评肢端肥大症症状问卷(PASQ)以及西安大略和麦克马斯特大学关节炎指数(WOMAC)。我们还通过病历审查获取了以下变量:年龄、体重指数(BMI)、疾病持续时间、既往手术史(是/否)、既往放疗史(是/否)、使用生长激素降低药物情况(是/否)、高血压(是/否)、糖尿病(是/否)以及疾病的生化控制情况(是/否):采用免疫放射分析法定量检测血清生长激素(GH)和胰岛素样生长因子-1(IGF-1)水平,以确定疾病的生化控制情况。已对结局指标与AcroQoL之间的相关性进行了分析。对于呈正态分布的连续数据(AcroQoL、PASQ、AcroQoL-B、AcroQoL-R、WOMAC-P),计算Pearson相关系数r;对于非正态分布数据(WOMAC、WOMAC-F、WOMAC-S、AcroQoL-P),计算Spearman等级相关系数;对于二元变量(疾病生化控制情况、使用生长激素降低药物情况、放疗、手术),计算点二列相关系数。对AcroQoL各子量表进行了相同的相关性分析。采用向后逐步分析的多元线性回归来评估相关变量对AcroQoL的影响。
AcroQoL与PASQ呈强负相关(r = -0.700,p < 0.001),与WOMAC呈负相关[rs(43) = -0.530,p < 0.001],在WOMAC各子量表中,与WOMAC-身体功能[rs(43) = -0.518,p < 0.001]、WOMAC-疼痛[r(43) = -0.428,p = 0.003]、WOMAC-僵硬[rs(43) = -0.393,p = 0.007]以及放疗[r(43) = -0.314,p =